Skip to main content
. 2020 Jul 17;10:11921. doi: 10.1038/s41598-020-68629-4

Table 1.

Top hits for drivers of centrosome amplification in human cancer.

Centrosome gene Known functions (especially centrosome-related functions) Hypothesis
CEP19 Ciliation; microtubule anchoring to the centrosome; inactivation results in morbid obesity Gain of function causes CA
CEP72 Centriolar satellite component; recruit key centrosomal proteins to centrosome; microtubule nucleation; BRCA1 interactor; overexpression increases CIN, aneuploidy, lagging chromosomes Gain of function causes CA
CEP76 Limits centriole duplication; depletion drives aberrant amplification of centrioles Loss of function causes CA
CTNNB1 Wnt signaling pathway; negative regulator of centrosome cohesion; overexpression of stabilized mutant increases centrosomes Gain of function causes CA
MCPH1 Neurogenesis; chromosome condensation; DNA damage response; restrains DNA damage-induced CA; germline mutations cause microcephaly Loss of function causes CA
NEURL4 Interacts with CP110 (important for limiting centriole elongation) Loss of function causes CA
NDRG1 Cell trafficking; regulates centrosome number Gain of function causes CA
NPM1 Ribosome biogenesis; depleting NPM1 results in CA Loss of function causes CA
PTK2 Cell migration, adhesion, spreading, actin reorganization, focal adhesion formation, proliferation, apoptosis Gain of function causes CA
SPATC1 Proximal centriole marker Gain of function causes CA
TBCCD1 Localizes to a region sub-proximal to centrioles; mutant cells have variable numbers of centrioles and centriole positioning defects required for mother-daughter centriole linkage and mitotic spindle orientation; migration Gain of function causes CA